Sudden Cardiac Death (SCD) is a harrowing and unforeseen incident characterized by the abrupt cessation of the heart's normal rhythm, resulting in a sudden and unexpected stoppage of heart function. Distinguished from a heart attack by its origin in an electrical malfunction rather than a blocked blood flow to the heart, SCD can strike individuals both with and without a documented history of heart disease, adding an element of unpredictability and gravity to its occurrence. This medical emergency demands immediate action, typically involving cardiopulmonary resuscitation (CPR) and the use of automated external defibrillators (AEDs) when available. Identifying and addressing underlying risk factors, such as coronary artery disease or specific heart conditions, becomes crucial in mitigating the chances of SCD. Despite strides in medical knowledge, SCD remains a pressing public health issue, underscoring the necessity for heightened awareness, prompt intervention, and ongoing research efforts to deepen our understanding of the contributing factors to this tragic event.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States